25 related articles for article (PubMed ID: 19437374)
1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
Wolff D; Radojcic V; Lafyatis R; Cinar R; Rosenstein RK; Cowen EW; Cheng GS; Sheshadri A; Bergeron A; Williams KM; Todd JL; Teshima T; Cuvelier GDE; Holler E; McCurdy SR; Jenq RR; Hanash AM; Jacobsohn D; Santomasso BD; Jain S; Ogawa Y; Steven P; Luo ZK; Dietrich-Ntoukas T; Saban D; Bilic E; Penack O; Griffith LM; Cowden M; Martin PJ; Greinix HT; Sarantopoulos S; Socie G; Blazar BR; Pidala J; Kitko CL; Couriel DR; Cutler C; Schultz KR; Pavletic SZ; Lee SJ; Paczesny S
Transplant Cell Ther; 2021 Oct; 27(10):817-835. PubMed ID: 34217703
[TBL] [Abstract][Full Text] [Related]
2. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM
Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DD
Am J Hematol; 2015 May; 90(5):392-9. PubMed ID: 25615933
[TBL] [Abstract][Full Text] [Related]
4. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
[TBL] [Abstract][Full Text] [Related]
5. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
[TBL] [Abstract][Full Text] [Related]
6. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB
Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
[TBL] [Abstract][Full Text] [Related]
7. [Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation].
Neid T; Danz B; Eismann R; Bramsiepe I; Wohlrab J; Marsch WC; Fiedler E
Dtsch Med Wochenschr; 2009 May; 134(21):1106-9. PubMed ID: 19437374
[TBL] [Abstract][Full Text] [Related]
8. Management of graft-versus-host disease.
Arai S; Vogelsang GB
Blood Rev; 2000 Dec; 14(4):190-204. PubMed ID: 11124107
[TBL] [Abstract][Full Text] [Related]
9. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
[No Abstract] [Full Text] [Related]
10. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Feinstein L; Sandmaier B; Maloney D; McSweeney PA; Maris M; Flowers C; Radich J; Little MT; Nash RA; Chauncey T; Woolfrey A; Georges G; Kiem HP; Zaucha JM; Blume KG; Shizuru J; Niederwieser D; Storb R
Ann N Y Acad Sci; 2001 Jun; 938():328-37; discussion 337-9. PubMed ID: 11458521
[TBL] [Abstract][Full Text] [Related]
11. Psoriasiform Graft-Versus-Host Disease: Report and Brief Review of the Literature.
Vernali S; Vertes George E; Gonzalez Santiago T; Motaparthi K
Am J Dermatopathol; 2018 Jul; 40(7):511-514. PubMed ID: 29293122
[TBL] [Abstract][Full Text] [Related]
12. Neurologic Complications of Transplantation.
Pruitt AA
Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):802-821. PubMed ID: 28570330
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]